Top ALK ex­pert and can­cer drug re­searcher Al­ice Shaw bids adieu to acad­e­mia, hel­lo to No­var­tis

Jay Brad­ner has re­cruit­ed a mar­quee on­col­o­gy drug re­searcher in­to the ranks of the No­var­tis In­sti­tutes for Bio­Med­ical Re­search. Al­ice Shaw is jump­ing from pres­ti­gious posts in­ter­twined through Mass Gen­er­al, Har­vard and Dana-Far­ber to take the lead of NI­BR’s trans­la­tion­al clin­i­cal on­col­o­gy group.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER